TABLE 2.
Availability of caregiver and surviving to 100 and 180 days after transplant, logistic regression without and with adjusting for covariates (N = 173).
| b | SE | Wald | df | p | OR | 95% CI |
||
| Lower | Upper | |||||||
| (a) Surviving to 100 days | ||||||||
| Univariate logistic regression | ||||||||
| Intercept | 0.83 | 0.45 | 3.33 | 1 | 0.068 | 2.29 | ||
| Caregiver | 1.05* | 0.51 | 4.15 | 1 | 0.042 | 2.84 | 1.04 | 7.77 |
| Multiple logistic regression | ||||||||
| Intercept | 1.56 | 0.93 | 2.80 | 1 | 0.094 | 4.76 | ||
| Caregiver | 1.11* | 0.55 | 4.05 | 1 | 0.044 | 3.03 | 1.03 | 8.90 |
| Age | –0.43 | 0.19 | 4.88 | 1 | 0.027 | 0.65 | 0.45 | 0.95 |
| Gender | –0.41 | 0.46 | 0.79 | 1 | 0.375 | 0.67 | 0.27 | 1.63 |
| Ethnic minority | –0.53 | 0.50 | 1.13 | 1 | 0.289 | 0.59 | 0.22 | 1.56 |
| Cancer type | –0.71 | 0.82 | 0.74 | 1 | 0.388 | 0.49 | 0.10 | 2.46 |
| HLA-identical sibling transplant | 1.49 | 0.59 | 6.46 | 1 | 0.011 | 4.44 | 1.41 | 14.01 |
| (b) Surviving to 180 days | ||||||||
| Univariate logistic regression | ||||||||
| Intercept | 0.26 | 0.42 | 0.39 | 1 | 0.533 | 1.30 | ||
| Caregiver | 0.75 | 0.46 | 2.66 | 1 | 0.103 | 2.12 | 0.86 | 5.21 |
| Multiple logistic regression | ||||||||
| Intercept | 0.44 | 0.67 | 0.43 | 1 | 0.513 | 1.55 | ||
| Caregiver | 0.77 | 0.47 | 2.66 | 1 | 0.103 | 2.15 | 0.86 | 5.42 |
| Age | –0.16 | 0.14 | 1.26 | 1 | 0.261 | 0.85 | 0.65 | 1.13 |
| Gender | –0.01 | 0.36 | 0.00 | 1 | 0.968 | 0.99 | 0.49 | 2.00 |
| Ethnic minority | 0.21 | 0.38 | 0.31 | 1 | 0.580 | 1.24 | 0.58 | 2.62 |
| Cancer type | –0.54 | 0.55 | 0.99 | 1 | 0.320 | 0.58 | 0.20 | 1.70 |
| HLA-identical sibling transplant | 0.56 | 0.38 | 2.25 | 1 | 0.134 | 1.76 | 0.84 | 3.66 |
b, regression weight; SE, standard error; Df, degrees of freedom; p, significance level; OR, odds ratio; CI, confidence interval with lower and upper limit.